National Research Corporation

NASDAQ:NRC

Medical - Healthcare Information Services

Healthcare
$26.16 +0.40%

+$0.07 today

Market cap
$555.16M
Beta
0.40
P/E (TTM)
43.0
EPS (TTM)
$0.41
Dividend yield
3.14%
52W Low $11.01High $22.79

Volume 0.09M

Average 0.11M

NRC Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

National Research CorporationNASDAQ: NRC

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $15.82M rose 8.3% year over year, ahead of the +6.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at +1.7% a year.

Context

  • Cost of revenue amounted to 43.7% of revenue in FY2025, up 3.9 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.3% holds above the trailing-twelve-month pace of +6.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.82M-1.7% QoQ
Last fiscal yearDec 2025
$60M+5.4% YoY
LTMMar 2026
$61.21M+6.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.3%——
1 year+5.4%——
3-year CAGR+1.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
60M USD
Year-over-year change
+5.4%
4-year CAGR
+3.5%

Cost of Revenue vs competitors

How NRC compares with its peers on the latest reported figures

  • NRC's LTM Mar 2026 cost of revenue of $61.21M is the 7th highest of the 8 companies compared; the peer median is $109.48M.
  • Its year-over-year change of +6.1% is the 7th highest of 8, against a peer median of +21.9%.
  • Cost of revenue amounts to 44.2% of revenue for NRC, versus a peer median of 35.1%.
NRC Competitors Peer median
Cost of Revenue for NRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CTEVClaritev CorporationLTM Mar 2026$381.09M +58.9%+50.7%38.9%
PHRPhreesia, Inc.LTM Apr 2026$169.46M +21.9%+12.1%34.2%
HCATHealth Catalyst, Inc.LTM Mar 2026$163.38M -4.2%+13.1%54.0%
HSTMHealthStream, Inc.LTM Mar 2026$109.48M +10.8%+5.6%35.1%
CCLDCareCloud, Inc.LTM Mar 2026$84.84M +38.8%-8.6%68.3%
DHDefinitive Healthcare Corp.LTM Mar 2026$65.42M +14.6%+11.0%27.5%
NRCNational Research CorporationLTM Mar 2026$61.21M +6.1%+1.7%44.2%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$26.56M +23.9%+21.8%32.7%
Peer median (excluding NRC) $109.48M+21.9%+12.1%35.1%

Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue147.95M151.57M148.58M143.06M137.39M
Cost of Revenue52.35M57.05M56.02M56.93M60M
Gross Profit95.6M94.52M92.57M86.13M77.4M
Gross Margin64.6%62.4%62.3%60.2%56.3%
Research & Development00000
Selling, General & Admin38.96M42.7M46.58M44.91M54.81M
Operating Expenses45.33M47.98M52.52M50.93M54.81M
Depreciation & Amortization6.37M5.28M5.9M6.02M7.62M
EBITDA56.66M49.3M45.99M41.31M30.23M
EBITDA Margin38.3%32.5%30.9%28.9%22.0%
Operating Income50.27M46.54M40.05M35.19M22.59M
Operating Margin34.0%30.7%27.0%24.6%16.4%
Interest Income14K168K820K125K111K
Interest Expense1.67M1.21M862K2.6M4.76M
Other Income / Expenses(1.65M)(3.73M)(83K)(2.5M)(4.75M)
Income Before Tax48.62M42.82M39.96M32.69M17.84M
Pre-Tax Margin32.9%28.2%26.9%22.9%13.0%
Income Tax Expense11.16M11.02M8.99M7.91M6.24M
Net Income37.47M31.8M30.97M24.78M11.6M
Net Margin25.3%21.0%20.8%17.3%8.4%
EPS (Basic)1.471.281.261.050.52
EPS (Diluted)1.461.271.251.040.52
Weighted Avg Shares25.42M24.92M24.54M23.72M22.38M
Weighted Avg Shares (Diluted)25.64M25.05M24.67M23.74M22.4M

National Research Corporation

NASDAQ:NRC

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.